Home › Atherosclerosis › Pennsylvania › Allentown
Atherosclerosis clinical trials in Allentown, PA
3 studies for Atherosclerosis are looking for participants at sites in and around Allentown (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
RecruitingPhase 3
- Lehigh Valley Health Network, Allentown
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
- Northeast Clinical Research Center, LLC, Bethlehem · 6 mi away
Pelacarsen Roll-over Extension Program
RecruitingPhase 3
- Care Access Research, Easton · 15 mi away
About Atherosclerosis
Atherosclerosis is hardening and narrowing of the arteries caused by the buildup of a fatty substance called plaque. Learn about the risks and prevention.
More about Atherosclerosis on MedlinePlus
Atherosclerosis trials in other cities
- Boston, MA10 studies
- Houston, TX10 studies
- Washington, DC9 studies
- Orlando, FL8 studies
- Arlington, VA8 studies
- Hialeah, FL8 studies
- Durham, NC7 studies
- Memphis, TN7 studies
- Dallas, TX7 studies
- Miami, FL7 studies
- Las Vegas, NV7 studies
- Minneapolis, MN6 studies
Other studies in Allentown
- Non-Small Cell Lung Cancer14 studies
- Breast Cancer10 studies
- Acute Myeloid Leukemia8 studies
- Lung Cancer7 studies
- Colorectal Cancer7 studies
- Major Depressive Disorder6 studies
- Melanoma6 studies
- Cancer (all types)6 studies
- Burkitt Lymphoma5 studies
- Ovarian Cancer5 studies
- Coronary Artery Disease5 studies
- Colon Cancer5 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.